Cargando…
Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Medizin
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420841/ https://www.ncbi.nlm.nih.gov/pubmed/34512805 http://dx.doi.org/10.1007/s15033-021-2738-4 |
| _version_ | 1783748960772423680 |
|---|---|
| author | Budweiser, Stephan |
| author_facet | Budweiser, Stephan |
| author_sort | Budweiser, Stephan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8420841 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Medizin |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84208412021-09-07 Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19 Budweiser, Stephan Pneumo News Journalclub Springer Medizin 2021-09-10 2021 /pmc/articles/PMC8420841/ /pubmed/34512805 http://dx.doi.org/10.1007/s15033-021-2738-4 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Journalclub Budweiser, Stephan Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19 |
| title | Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19 |
| title_full | Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19 |
| title_fullStr | Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19 |
| title_full_unstemmed | Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19 |
| title_short | Tocilizumab senkt Mortalität bei hyperinflammatorischer COVID-19 |
| title_sort | tocilizumab senkt mortalität bei hyperinflammatorischer covid-19 |
| topic | Journalclub |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8420841/ https://www.ncbi.nlm.nih.gov/pubmed/34512805 http://dx.doi.org/10.1007/s15033-021-2738-4 |
| work_keys_str_mv | AT budweiserstephan tocilizumabsenktmortalitatbeihyperinflammatorischercovid19 |